Back to GetFilings.com




 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 


 

Form 10-Q

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
     SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
     SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                  to                 .

 

Commission file number - 333-56097

 


 

HUDSON RESPIRATORY CARE INC.

(Exact name of registrant as specified in its charter)

 

California   95-1867330

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

27711 Diaz Road, P.O. Box 9020

Temecula, California

  92589
(Address of Principal Executive Offices)   (Zip Code)

 

(909) 676-5611

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report).

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ¨    Not Applicable  x

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined by Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

 

The number of shares of Common Stock, $0.01 par value, outstanding (the only class of common stock of the Company outstanding) was 10,654,293 on May 7, 2004.

 



HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

 

QUARTER ENDED MARCH 31, 2004

 

TABLE OF CONTENTS

 

             Page

PART I

 

FINANCIAL INFORMATION

    
   

Item 1.

  Unaudited Condensed Consolidated Financial Statements:     
        Unaudited Condensed Consolidated Balance Sheets as of March 31, 2004 and December 31, 2003    1
        Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2004 and March 31, 2003    3
        Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2004 and March 31, 2003    4
        Notes to Unaudited Condensed Consolidated Financial Statements    6
   

Item 2.

  Management’s Discussion and Analysis of Financial Condition and Results of Operations    12
   

Item 3.

  Quantitative and Qualitative Disclosures About Market Risks    16
   

Item 4.

  Controls and Procedures    16

PART II

 

OTHER INFORMATION

    
   

Item 1.

  Legal Proceedings    16
   

Item 2.

  Changes in Securities    16
   

Item 3.

  Defaults Upon Senior Securities    16
   

Item 4.

  Submission of Matters to a Vote of Security Holders    16
   

Item 5.

  Other Information    16
   

Item 6.

  Exhibits and Reports on Form 8-K    16

SIGNATURE

           17

 

i


HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

(A majority-owned subsidiary of River Holding Corp.)

 

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

 

ASSETS

 

(amounts in thousands)

 

    

March 31,

2004


  

December 31,

2003


CURRENT ASSETS:

             

Cash

   $ 6,299    $ 6,682

Accounts receivable, less allowance for doubtful accounts of $1,217 and $1,156 at March 31, 2004 and December 31, 2003, respectively

     27,319      25,107

Inventories, net

     24,074      23,829

Other current assets

     2,455      2,505
    

  

Total current assets

     60,147      58,123

PROPERTY, PLANT AND EQUIPMENT, net

     37,927      37,477

GOODWILL

     39,822      41,410

DEFERRED FINANCING AND OTHER COSTS, net of accumulated amortization of $5,457 and $5,188 at March 31, 2004 and December 31, 2003, respectively

     6,169      6,457

OTHER ASSETS

     1,288      1,243
    

  

Total other assets

     47,279      49,110
    

  

Total assets

   $ 145,353    $ 144,710
    

  

 

See notes to condensed consolidated statements

 

1


HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

(A majority-owned subsidiary of River Holding Corp.)

 

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

(amounts in thousands, except per share amounts)

 

    

March 31,

2004


   

December 31,

2003


 

CURRENT LIABILITIES:

                

Current portion of bank notes payable

   $ 8,968     $ 9,178  

Accounts payable

     10,652       9,175  

Accrued liabilities

     17,714       16,973  
    


 


Total current liabilities

     37,334       35,326  

INTEREST PAYABLE TO AFFILIATES

     11,161       9,760  

NOTES PAYABLE TO AFFILIATES

     39,317       39,317  

BANK NOTES PAYABLE, net of current portion

     50,176       54,377  

SENIOR SUBORDINATED NOTES PAYABLE

     115,000       115,000  

MANDATORILY REDEEMABLE PREFERRED STOCK, $0.01 par value; 2,990 shares authorized; 556 shares issued and outstanding at March 31, 2004 and December 31, 2003; liquidation preference, $58,550

     55,166       55,147  

Accrued preferred stock dividend, payable in kind

     2,932       1,333  
    


 


       58,098       56,480  

OTHER NON-CURRENT LIABILITIES

     2,286       2,365  
    


 


Total liabilities

     313,372       312,625  

COMMITMENTS AND CONTINGENCIES (Note 4)

                

STOCKHOLDERS’ DEFICIT:

                

Junior preferred stock, $0.01 par value; 10 shares authorized; 3 shares outstanding at March 31, 2004 and December 31, 2003

     4,076       3,960  

Common stock, $0.01 par value; 42,000 shares authorized; 10,654 issued and outstanding at March 31, 2004 and December 31, 2003

     98,258       98,258  

Additional paid in capital

     881       881  

Cumulative translation adjustment

     5,509       6,848  

Accumulated deficit

     (276,743 )     (277,862 )
    


 


Total stockholders’ deficit

     (168,019 )     (167,915 )
    


 


Total liabilities and stockholders’ deficit

   $ 145,353     $ 144,710  
    


 


 

See notes to condensed consolidated statements

 

2


HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

(A majority-owned subsidiary of River Holding Corp.)

 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

(amounts in thousands)

 

     Three Months Ended

    

March 31,

2004


   

March 31,

2003


NET SALES

   $ 50,183     $ 45,879

COST OF SALES

     26,230       26,030
    


 

Gross Profit

     23,953       19,849

OPERATING EXPENSES:

              

Distribution, selling, general & administrative

     14,106       12,757

Research and development

     859       640
    


 

       14,965       13,397
    


 

Income from operations

     8,988       6,452

INTEREST EXPENSE AND OTHER, net

     7,080       5,261
    


 

Net income before provision for income taxes

     1,908       1,191

PROVISION FOR INCOME TAXES

     674       681
    


 

Net income

   $ 1,234     $ 510
    


 

OTHER COMPREHENSIVE INCOME (LOSS):

              

Foreign currency translation (loss) gain

     (1,339 )     721
    


 

Comprehensive (loss) income

   $ (105 )   $ 1,231
    


 

 

See notes to condensed consolidated statements

 

3


HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

(A majority-owned subsidiary of River Holding Corp.)

 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

(amounts in thousands)

 

     Three Months Ended

 
    

March 31,

2004


   

March 31,

2003


 

CASH FLOWS FROM OPERATING ACTIVITIES:

                

Net income

   $ 1,234     $ 510  

Adjustments to reconcile net income to net cash provided by operating activities—

                

Depreciation and amortization

     2,481       2,405  

Amortization of deferred financing costs

     269       464  

Accrued mandatorily redeemable preferred stock dividends, payable in-kind

     1,618       —    

Interest payable to affiliates

     1,402       1,064  

Provision for bad debts

     88       197  

Loss (gain) on disposal of property, plant and equipment

     11       (6 )

Changes in operating assets and liabilities:

                

Accounts receivable

     (2,618 )     342  

Inventories

     (422 )     1,413  

Other current assets

     13       (799 )

Other assets

     (46 )     (19 )

Accounts payable

     1,543       (625 )

Accrued liabilities

     885       2,047  

Other non-current liabilities

     18       12  
    


 


Net cash provided by operating activities

     6,476       7,005  

CASH FLOWS FROM INVESTING ACTIVITIES:

                

Purchases of property, plant and equipment

     (3,024 )     (1,723 )

Proceeds from sales of property, plant and equipment

     2       17  
    


 


Net cash used in investing activities

     (3,022 )     (1,706 )

CASH FLOWS FROM FINANCING ACTIVITIES:

                

Repayment of bank notes payable

     (4,317 )     (7,734 )

Proceeds from bank borrowings

     408       1,582  

Payment of capital lease obligations

     (14 )     (13 )
    


 


Net cash used in financing activities

     (3,923 )     (6,165 )

Effect of exchange rate changes on cash

     86       (292 )
    


 


NET DECREASE IN CASH

     (383 )     (1,158 )

CASH, beginning of period

     6,682       6,425  
    


 


CASH, end of period

   $ 6,299     $ 5,267  
    


 


 

See notes to condensed consolidated statements

 

4


     Three Months Ended

    

March 31,

2004


  

March 31,

2003


SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

             

Cash paid during the period for:

             

Interest

   $ 932    $ 1,076
    

  

Income taxes (primarily foreign)

   $ 365    $ 1,138
    

  

NON-CASH FINANCING ACTIVITIES:

             

Preferred dividends accrued or paid-in-kind

   $ 116    $ 1,533
    

  

 

See notes to condensed consolidated statements

 

5


HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

(A majority-owned subsidiary of River Holding Corp.)

 

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1. Financial Statements. The condensed consolidated financial statements included herein have been prepared by the Company, without audit, and include all adjustments which are, in the opinion of management, necessary for a fair presentation of the financial position at March 31, 2004, the results of operations for the three month periods ended March 31, 2004 and March 31, 2003 and statements of cash flows for the three month periods ended March 31, 2004 and March 31, 2003 pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. Although the Company believes that the disclosures in such financial statements are adequate to make the information presented not misleading, the accompanying unaudited condensed, consolidated financial statements should be read in conjunction with the Company’s 2003 audited financial statements and the notes thereto included in its Form 10-K filed with the SEC. The results of operations for the three month period ended March 31, 2004 are not necessarily indicative of the results to be achieved for a full year.

 

Significant Accounting Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

The significant estimates made in the preparation of the Company’s consolidated financial statements relate to allowance for bad debts, rebate reserve, and inventory reserve.

 

Stock Based Compensation

 

The Company accounts for its stock-based compensation plans under the recognition and measurement principles of Accounting Principles Board Opinion (“APB”) 25, “Accounting for Stock Issued to Employees,” and related interpretations. The Company has adopted the disclosure provisions of Statement Financial Accounting Standards (“SFAS”) 123, “Accounting for Stock-Based Compensation,” as amended by SFAS 148, “Accounting for Stock-Based Compensation – Transition and Disclosure – an amendment of FASB Statement No. 123.” No stock-based employee compensation expense is recognized in net income for any of the periods presented. Had compensation expense for the Company’s stock-based compensation awards been recognized based on the fair value recognition provisions of SFAS 123, the Company’s net income would have been adjusted to the pro forma amounts indicated below (amounts in thousands):

 

     Three Months Ended March 31,

     2004

   2003

Net income, as reported

   $ 1,234    $ 510

Deduct: Total stock-based employee compensation expense determined under the fair value based method for all awards

     33      3
    

  

Pro forma net income

   $ 1,201    $ 507
    

  

 

Under the fair-value method, compensation expense is measured at the grant date based on the fair value of the award using an option-pricing model. Compensation expense is recognized on a straight-line basis over the

 

6


vesting period. The fair value of employee stock options was estimated using the Black-Scholes option-pricing model with the following weighted-average assumptions used for grants in 2003 and 2002: risk-free interest rates of 2.00% and 2.83%, respectively; dividend yield of 0% for all years; expected lives of three years and four years, respectively, and volatility of 50% for both years.

 

Reclassifications

 

Certain amounts from prior periods have been reclassified to conform to the current period presentation.

 

2. Inventories. Inventories consisted of the following (amounts in thousands):

 

    

March 31,

2004


  

December 31,

2003


Raw materials

   $ 4,587    $ 4,558

Work-in-process

     5,113      4,955

Finished goods

     14,374      14,316
    

  

     $ 24,074   <